Diogo Souza Domiciano

Diogo Souza Domiciano

Auto-generated profile, based on publicly available information

Diogo Souza Domiciano

Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Archives of Osteoporosis
Verified
Journal Article
Closed access
PDF file
RPRosa Maria L.N. Pereira
Rosa Maria L.N. Pereira
MPMariana O. Perez
Mariana O. Perez
APAna Patrícia Paula
Ana Patrícia Paula
CMCaio Moreira
Caio Moreira
CCCharlles H. M. Castro
Charlles H. M. Castro
VSVera L. Szejnfeld
Vera L. Szejnfeld

26 July 2023 in Advances in Rheumatology
Verified
Journal Article
Open access
PDF file
KBKarina Rossi Bonfiglioli
Karina Rossi Bonfiglioli
ARAna Cristina de Medeiros Ribeiro
Ana Cristina de Medeiros Ribeiro
ACAna Paula Carnieletto
Ana Paula Carnieletto
IPIvânio Pereira
Ivânio Pereira
DDDiogo Souza Domiciano
Diogo Souza Domiciano
GCGeraldo da Rocha Castelar-Pinheiro
Geraldo da Rocha Castelar-Pinheiro
Introduction: Although Rheumatoid Arthritis (RA) extra-articular manifestations (ExtRA) occurrence has been decreasing over time, they are still a major mortality risk factor for patients. Objective: To determine the prevalence of ExtRA in a large cohort, and its association with demographic and clinical variables. Method: Cross-sectional and observational study, based on a multi-centric database from a prospective cohort, in which 11 public rheumatology centres enrolled RA patients (1987 ARA or 2010 ACR-EULAR). Data collection began in 08-2015, using a single online electronic medical record. Continuous variables were compared using Mann–Whitney U-test, and Fisher’s exact test or chi-square test, as appropriate, were used for categorical variables. The level of significance was set at 5% (p < 0.05). Results: 1115 patients were included: 89% women, age [mean ± SD] 58.2 ± 11.5 years, disease duration 14.5 ± 12.2 years, positive Rheumatoid Factor (RF, n = 1108) in 77%, positive anti-cyclic citrullinated peptide (ACPA, n = 477) in 78%. Regarding ExtRA, 334 occurrences were registered in 261 patients, resulting in an overall prevalence of 23.4% in the cohort. The comparison among ExtRA and Non-ExtRA groups shows significant higher age (p < 0.001), disease duration (p < 0.001), RF high titers (p = 0.018), Clinical Disease Activity index (CDAI) (p < 0.001), Disease Activity Index 28 (DAS 28) (p < 0.001), and Health Assessment Questionnaire (HAQ) (p < 0.001) in ExtRA group. Treatment with Azathioprine (p = 0.002), Etanercept (p = 0.049) Glucocorticoids (GC) (‘p = 0.002), and non-steroidal anti-inflammatory drugs (NSAIDs) (p < 0.001) were more frequent in ExtRA group. Conclusions: ExtRA manifestations still show an expressive occurrence that should not be underestimated. Our findings reinforce that long-term seropositive disease, associated with significant disability and persistent inflammatory activity are the key factors related to ExtRA development.

1 October 2020 in Journal of Clinical Densitometry
Verified
Journal Article
Closed access
GCGabriela D. Carvalho
Gabriela D. Carvalho
KBKarina Bonfiglioli
Karina Bonfiglioli
VCValéria F. Caparbo
Valéria F. Caparbo
LTLiliam Takayama
Liliam Takayama
RPRosa Maria L.N. Pereira
Rosa Maria L.N. Pereira
DDDiogo S. Domiciano
Diogo S. Domiciano


25 January 2024 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
FSFelipe F. Silva
Felipe F. Silva
GMGisela R. Machado
Gisela R. Machado
ARAna C. M. Ribeiro
Ana C. M. Ribeiro
KBKarina R. Bonfiglioli
Karina R. Bonfiglioli
ASAndrea Y. Shimabuco
Andrea Y. Shimabuco
DDDiogo S. Domiciano
Diogo S. Domiciano

31 October 2024 in Bone
Verified
Journal Article
Closed access
GVGabriel V. Valente
Gabriel V. Valente
LMLuana G. Machado
Luana G. Machado
CFCamille P. Figueiredo
Camille P. Figueiredo
VCValéria F. Caparbo
Valéria F. Caparbo
LTLiliam Takayama
Liliam Takayama
DDDiogo S. Domiciano
Diogo S. Domiciano